M.M.G. Drugs Profile
Key Indicators
- Authorised Capital ₹ 1.70 M
as on 24-12-2024
- Paid Up Capital ₹ 1.70 M
as on 24-12-2024
- Company Age 28 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.80 Cr
as on 24-12-2024
- Revenue %
(FY 2020)
- Profit -4.76%
(FY 2020)
- Ebitda -66.67%
(FY 2020)
- Net Worth -82.92%
(FY 2020)
- Total Assets -55.82%
(FY 2020)
About M.M.G. Drugs
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.70 M and a paid-up capital of Rs 1.70 M.
The company currently has active open charges totaling ₹2.80 Cr.
Subhash Miglani, Rajeev Goel, and Sanjay Kumar serve as directors at the Company.
- CIN/LLPIN
U85110HR1996PTC033063
- Company No.
033063
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Apr 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- LocationHaryana, Haryana
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at M.M.G. Drugs?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Miglani  | Director | 16-Jul-1999 | Current |
| Rajeev Goel | Director | 14-Feb-2000 | Current |
| Sanjay Kumar | Director | 14-Feb-2000 | Current |
Financial Performance of M.M.G. Drugs.
M.M.G. Drugs Pvt. Ltd., for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a slight decrease in profitability, with a 4.76% decrease in profit. The company's net worth observed a substantial decline by a decrease of 82.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of M.M.G. Drugs?
In 2019, M.M.G. Drugs had a promoter holding of 46.35% and a public holding of 53.65%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Alps Communication Private LimitedActive 27 years 9 monthsSubhash Miglani, Rajeev Goel and 1 more are mutual person
B.J. Accessories Private LimitedActive 19 years 11 daysSubhash Miglani, Rajeev Goel and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 05 Jan 2007 | ₹2.80 Cr | Open |
How Many Employees Work at M.M.G. Drugs?
Unlock and access historical data on people associated with M.M.G. Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of M.M.G. Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped M.M.G. Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
